Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery
Recruiting
Early Phase 1
Interventional Study
Cesarean Delivery
Postpartum Hemorrhage (PPH)
Intraoperative Blood Loss
Hemostasis
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 51
- Sex
- Female
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 112 (estimated)
- Sponsor
- Wolfson Medical Center · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn whether applying topical tranexamic acid (TXA) directly to the uterine incision during cesarean delivery can reduce surgical bleeding compared to placebo. The study will include pregnant women aged 18-51 undergoing elective cesarean delivery at term (37 weeks or more).
The main questions it aims to answer are:
* Does topical TXA shorten uterine closure…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women aged 18 to 51 years
* Singleton pregnancy
* Elective cesarean delivery scheduled at ≥37+0 weeks of gestation
* First or second cesarean delivery only
* Low transverse uterine incision planned
* Double-layer uterine closure using 1-0 Vicryl sutures
* Ability to provide wr…
Contacts